Riskpilot← Back to searchSign inGet full accessSorbus Doctor Ab
OYActiveY-tunnus 2414167-6Tirholmsvägen 25-B2Medical specialists activities · NACE 8622Est. 2011— employees
Revenue 2025
EUR 56K
+47% vs 2024
EBITDA margin
24.2%
-86% vs 2024
Equity ratio
94.9%
Financial strength
Net profit 2025
EUR 11K
+4000% vs 2024
| Revenue | EUR 56K | +47% |
| EBITDA | EUR 13K | -86% |
| Net profit | EUR 11K | +4000% |
| Total assets | EUR 91K | +14% |
| Equity | EUR 87K | +14% |
| Employees | — | — |
Legal name
Sorbus Doctor Ab
Y-tunnus number
2414167-6
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
14. kesäkuuta 2011
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Bolagets verksamhetsområde är producerande av sjukvårdstjänster åt patienter, till branschen hörande forskningsarbete, konsulterings- och föreläsningsuppgifter samt import och export av med hälsovården förknippade apparater och tillbehör samt förlags verksamhet. Bolaget kan äga, besitta och hyra fastigheter ävensom affärs- och bostadslägenheter. Bolaget kan utöva uthyrning av fordon. Bolaget kan utöva handel med värdepapper.
Address
Tirholmsvägen 25-B2
Phone
+3580504666298
Email
mats@ronnback.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 51 | 69 | 53 | 38 | 56 |
| Staff expenses | −23 | −18 | −23 | 29 | −20 |
| EBITDA | −65 | −2 | 11 | 98 | 13 |
| Depreciation & amort. | −4 | −3 | −2 | — | — |
| EBIT | −69 | −5 | 9 | −22 | 13 |
| Net financials | 20 | −364 | 0 | — | — |
| Profit before tax | −15 | 1 | −75 | −23 | 14 |
| Tax | −0 | −0 | 2 | 0 | −3 |
| Net profit | −15 | 1 | −77 | 0 | 11 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 514 | 414 | 389 | 80 | 91 |
| Equity | 152 | 152 | 75 | 76 | 87 |
| Long-term debt | 357 | 257 | 0 | 0 | — |
| Short-term debt | 5 | 5 | 313 | 4 | 5 |
| Total debt | 362 | 262 | 313 | 4 | 5 |
EBITDA margin
24.2%
This company
15.8%
Market median
+53% vs market
20212025
Equity ratio
94.9%
This company
38.2%
Market median
+148% vs market
20212025
Return on equity
12.5%
This company
18.4%
Market median
+32% vs market
20212025
Net profit margin
19.4%
This company
8.1%
Market median
+140% vs market
20212025
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JF Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2011 |
MJ Chief Executive Officer | Chief Executive Officer | 2011 |
| Former (1) | ||
EM | Audit | 2011 – 2025 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sorbus Doctor Ab also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Fredrik Rönnback | Deputy Chief Executive Officer | 0 companies |
| Mats Johan Rönnback | Chief Executive Officer | 0 companies |
| Eva Maria Kurman-Munck | Audit | 0 companies |